EUVIMEDEUVIMED entdecken
Crossref

Narrative review of chronic active EBV infection—advances in clinical management

Akihisa Sawada, Masami Inoue

Annals of Lymphoma · 2021

DOI: 10.21037/aol-20-34 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Lymphoma, 2021. Verfasst von Akihisa Sawada und 1 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic active Epstein-Barr virus infection (CAEBV) is a prototype of EBV-associated T- and NK-cell lymphoproliferative diseases (T/NK-cell LPDs). It is a highly progressive disease with fatal organ failure, severe hypercytokinemia [“CAEBV flare”; including hemophagocytic lymphohistiocytosis (HLH)], and overt lymphomatous/leukemic changes. Children and adolescents with CAEBV mostly die within 5–10 years. The progression of adult-onset CAEBV is two-fold faster. We herein present a narrative review. Since CAEBV is a rare disease, limited information is currently available on its treatment. Therefore, we describe our experience of treating CAEBV in addition to a literature review. CAEBV shows a spectrum for its severity and neoplastic nature. Patients will not recover without radical treatment, and mostly require allogeneic hematopoietic stem cell transplantation (HSCT). We established a treatment strategy comprising three steps: cooling [immunochemotherapy with prednisolone (PSL), cyclosporine A (CsA), and etoposide (Etp)], cytoreduction (multidrug-combination block chemotherapy), and reconstruction (allogeneic HSCT). The three-step strategy is applicable to patients at any status of the CAEBV spectrum for improved survival and quality of life. The 3-year overall survival (OS) rate was 76%. Planned HSCT with stable disease or a less active disease status has been successfully performed, and the OS rate is approximately 90%. In contrast, the prognosis of patients with severe disease activity even after chemotherapy is poor (OS rate

Zitieren

APA

Sawada, A., & Inoue, M. (2021). Narrative review of chronic active EBV infection—advances in clinical management. Annals of Lymphoma. https://doi.org/10.21037/aol-20-34

Vancouver

Sawada A, Inoue M. Narrative review of chronic active EBV infection—advances in clinical management. Annals of Lymphoma. 2021. doi:10.21037/aol-20-34

BibTeX
@article{Sawada2021,
  author = {Sawada, Akihisa and Inoue, Masami},
  title = {Narrative review of chronic active EBV infection—advances in clinical management},
  journal = {Annals of Lymphoma},
  year = {2021},
  doi = {10.21037/aol-20-34}
}
Kostenlos starten →